Pelthos Therapeutics Inc.
PTHSPelthos Therapeutics Inc.
AMEX
Healthcare
Biotechnology
$20.40
-0.90(-4.2%)
52W $11.70 – $37.42
AI-generated
Pelthos Therapeutics Inc.
Revenue breakdown: Net Product (96.5%), License And Collaboration (3.5%).
$13MMkt Cap
—Rev TTM
—NI TTM
Latest Earnings
10-K
FY FY2025Mar 18, 2026Pelthos Therapeutics Inc. (PTHS) reported total revenue of $16.8 million for FY 2025, driven entirely by net product revenues from ZELSUVMI launched in July 2025, marking the company's first full year of commercialization post-merger with LNHC. Cost of goods sold was $4.0 million, resulting in a gross profit of $12.8 million. Operating expenses totaled $49.2 million, including $42.5 million in...
What Changed Recently
Fundamentals
How The Business Makes Money
Revenue by Segment
Net Product96.5%($16M)
License And Collaboration3.5%($589.0K)
Analyst View
Company Profile
CIK0001919246
ISINUS1711262048
Phone877 265 8266
Address4020 Stirrup Creek Drive, Suite 110, Durham, NC 27703, Durham, NC, 27703, US
SEC EDGAR